CARTESIAN THERAPEUTICS, INC.

Analyst Reco. Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Market Closed - Nasdaq Other stock markets 01:30:01 02/05/2024 am IST			5-day change	1st Jan Change
22.66 ^USD	+2.67%		+9.36%	+9.56%

23/04	Leerink Partners Starts Cartesian Therapeutics With Outperform Rating, $39 Price Target	MT
14/03	Cartesian Therapeutics, Inc Receives Notice from Audentes Therapeutics, Inc of Astellas? Termination of the License and Development Agreement	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Leerink Partners Starts Cartesian Therapeutics With Outperform Rating, $39 Price Target	23/04	MT
Mizuho Trims Price Target on Selecta Biosciences to $3 From $4, Maintains Buy Rating	18/23/18	MT
Needham Adjusts Price Target on Selecta Biosciences to $4 From $5, Maintains Buy Rating	18/23/18	MT
HC Wainwright Adjusts Price Target on Selecta Biosciences to $5 From $4, Maintains Buy Rating	22/23/22	MT
Mizuho Securities Adjusts Selecta Biosciences Price Target to $4 From $5, Maintains Buy Rating	22/23/22	MT
Canaccord Genuity Adjusts Selecta Biosciences Price Target to $9 From $10, Maintains Buy Rating	31/23/31	MT
HC Wainwright Adjusts Price Target on Selecta Biosciences to $4 From $6, Reiterates Buy Rating	21/22/21	MT
Needham Adjusts Price Target on Selecta Biosciences to $5 From $6, Reiterates Buy Rating	14/22/14	MT
SVB Securities Initiates Selecta Biosciences at Outperform With $7 Price Target	06/22/06	MT
SELECTA BIOSCIENCES : BTIG Starts Selecta Biosciences at Buy With $10 Price Target	15/21/15	MT
SELECTA BIOSCIENCES : William Blair Upgrades Selecta Biosciences to Outperform from Market Perform	12/21/12	MT
SELECTA BIOSCIENCES : Mizuho Upgrades Selecta Biosciences to Buy From Neutral, Adjusts Price Target to $8 From $2.50	26/21/26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer